Sign up to save your podcasts
Or
Share 60 - Nivolumab-AVD Versus Brentuximab Vedotin–AVD in Older Patients With Advanced-Stage Classic Hodgkin Lymphoma Enrolled on S1826
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
60 - Nivolumab-AVD Versus Brentuximab Vedotin–AVD in Older Patients With Advanced-Stage Classic Hodgkin Lymphoma Enrolled on S1826
Discussão do artigo: "Nivolumab-AVD Versus Brentuximab
Vedotin–AVD in Older Patients With Advanced-Stage Classic Hodgkin Lymphoma Enrolled on S1826" de Rutherford S JCO 2025
Apresentado por: Dra. Ilana Barcessat
Discussão por: Dr. Eduardo Burlamaqui, Dr. Rafael Faust, Dr. Guilherme Rodrigues, Dr. Pedro Moraes e Dr. Vinícius Molla
View all episodes
By TMO EPM / Hemato H9JDiscussão do artigo: "Nivolumab-AVD Versus Brentuximab
Vedotin–AVD in Older Patients With Advanced-Stage Classic Hodgkin Lymphoma Enrolled on S1826" de Rutherford S JCO 2025
Apresentado por: Dra. Ilana Barcessat
Discussão por: Dr. Eduardo Burlamaqui, Dr. Rafael Faust, Dr. Guilherme Rodrigues, Dr. Pedro Moraes e Dr. Vinícius Molla